株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

生検針の世界市場:種類(使い捨て・再利用)、癌の種類(骨髄腫・乳癌・肺癌・肝癌・前立腺癌)、地域別の予測

Biopsy Needles Market: By Type (Disposable, Non Disposable); By Cancer Type (Bone Marrow, Breast, Lung, Liver, Prostate) & By Region (Europe, Asia-Pacific, North America, RoW)-Forecast 2019-2024

発行 IndustryARC 商品コード 422705
出版日 ページ情報 英文
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=110.56円で換算しております。
Back to Top
生検針の世界市場:種類(使い捨て・再利用)、癌の種類(骨髄腫・乳癌・肺癌・肝癌・前立腺癌)、地域別の予測 Biopsy Needles Market: By Type (Disposable, Non Disposable); By Cancer Type (Bone Marrow, Breast, Lung, Liver, Prostate) & By Region (Europe, Asia-Pacific, North America, RoW)-Forecast 2019-2024
出版日: 2018年12月14日 ページ情報: 英文
概要

当レポートでは、生検針の世界市場について調査し、生検針の種類、癌の種類、地域別の市場動向および市場成長予測、市場の促進・抑制要因、市場の機会・課題、戦略分析、主要企業のプロファイルなどをまとめています。

第1章 市場概要

第2章 エグゼクティブサマリー

第3章 市場情勢

  • 市場シェア分析
  • 比較分析
  • 製品ベンチマーク
  • エンドユーザーのプロファイル
  • トップ5社の財務分析

第4章 市場力学

  • 市場の促進要因
  • 市場の抑制要因
  • 市場の機会
  • 市場の課題
  • ファイブフォース分析

第5章 生検針の世界市場:戦略分析

  • バリューチェーン分析
  • 価格分析
  • 市場機会分析
  • 製品/市場のライフサイクル分析
  • 供給・流通

第6章 生検針の世界市場:種類別

  • 使い捨て生検針
  • 再利用生検針

第7章 生検針の世界市場:癌の種類別

  • 骨髄腫
  • 乳癌
  • 肺癌
  • 肝癌
  • 前立腺癌
  • その他

第8章 生検針の世界市場:地域別

  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ロシア
    • 英国
    • その他の国々
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他の国々
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • その他の地域
    • ブラジル
    • その他の国々

第9章 生検針の世界市場:エントロピー

  • 市場の拡大
  • 技術の進歩
  • 合併・買収・合弁事業
  • 供給契約

第10章 企業プロファイル

第11章 付録

目次

Biopsy needles can be defined as a medical instrument used to perform a biopsy, which is a procedure to obtain a sample of cells from your body for laboratory testing. Common needle biopsy procedures include fine-needle aspiration and core needle biopsy. Needle biopsy may be used to take tissue or fluid samples from muscles, bones, and other organs, such as the liver or lungs. Globally, increasing prevalence of cancer and increasing healthcare spending are expected to drive the demand for biopsy needles during the period of study.

Geographically, North America dominated the biopsy needles market driven by world class healthcare infrastructure with a technologically advanced practice, higher spending and presence of key industry players in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for biopsy needles market. Asia Pacific is projected to have the fastest growth, owing to rapidly developing medical infrastructure, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region.

This report identifies the biopsy needles market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the biopsy needles market.

This report segments the biopsy needles market on the basis of needle type, cancer type and regional market as follows:

Biopsy needles market research report is classified on the basis of needle type. Some of the major needle types covered in this report are as follows: Disposable Needle and Non Disposable Needle

Biopsy needles market research report is classified on the basis of cancer type. Some of the major cancer type covered in this report are as follows: Bone Marrow Cancer, Breast Cancer, Lung Cancer, Liver Cancer, Prostate Cancer and Others

This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

This report identifies all the major companies operating in the biopsy needles market. Some of the major companies' profiles in detail are as follows:

Medax Medical Devices

Creganna Medica

Angiotech

Argon Medical devices

Cardinal Health, Inc.

Table of Contents

1. Biopsy needles Market - Overview

2. Executive Summary

3. Biopsy needles Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
  • 3.3. Product Benchmarking
  • 3.4. End User Profiling
  • 3.5. Top 5 Financials Analysis

4. Biopsy needles Market- Forces

  • 4.1. Drivers
    • 4.1.1. Increasing prevalence of cancer
  • 4.2. Restraints
  • 4.3. Opportunities
  • 4.4. Challenges
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers
    • 4.5.2. Bargaining Power of Buyers
    • 4.5.3. Threat of New Entrants
    • 4.5.4. Threat of Substitutes
    • 4.5.5. Degree of Competition

5. Biopsy needles Market- Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Opportunities Analysis
  • 5.4. Product/Market Life Cycle Analysis
  • 5.5. Suppliers and Distributors

6. Biopsy needles Market, By Type

  • 6.1. Disposable
  • 6.2. Non Disposable

7. Biopsy needles Market, By Cancer Type

  • 7.1. Bone Marrow
  • 7.2. Breast
  • 7.3. Lung
  • 7.4. Liver
  • 7.5. Prostate
  • 7.6. Others

8. Biopsy needles Market, By Geography

  • 8.1. Europe
    • 8.1.1. Germany
    • 8.1.2. France
    • 8.1.3. Italy
    • 8.1.4. Spain
    • 8.1.5. Russia
    • 8.1.6. U.K.
    • 8.1.7. Rest of Europe
  • 8.2. Asia Pacific
    • 8.2.1. China
    • 8.2.2. India
    • 8.2.3. Japan
    • 8.2.4. South Korea
    • 8.2.5. Rest of Asia-Pacific
  • 8.3. North America
    • 8.3.1. U.S.
    • 8.3.2. Canada
    • 8.3.3. Mexico
  • 8.4. Rest of the World (RoW)
    • 8.4.1. Brazil
    • 8.4.2. Rest of RoW

9. Biopsy needles Market - Entropy

  • 9.1. Expansion
  • 9.2. Technological Developments
  • 9.3. Merger & Acquisitions, and Joint Ventures
  • 9.4. Supply- Contract

10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)

  • 10.1. Medax Medical Devices
  • 10.2. Creganna Medica
  • 10.3. Angiotech
  • 10.4. Argon Medical devices
  • 10.5. Cardinal Health, Inc.
  • 10.6. Carefusion Corporation
  • 10.7. C.R. Bard, Inc.
  • 10.8. C.R. Bard, Inc.
  • 10.9. DTR Medical
  • 10.10. Hologic, Inc.
  • 10.11. INRAD, Inc.

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

11. Appendix

  • 11.1. Abbreviations
  • 11.2. Sources
  • 11.3. Research Methodology
  • 11.4. Bibliography
  • 11.5. Compilation of Expert Insights
  • 11.16. Disclaimer
Back to Top